Introduction
Depression, characterized by sadness or irritability, is a serious psychiatric disorder affecting ~121 million people worldwide. It is accompanied by several psychophysiological changes such as anhedonia, slowing of speech and actions, and suicidal thoughts. 1 Thus far, the diagnosis and treatment of depression have primarily relied on subjective criteria such as those outlined in the "Diagnostic and Statistical Manual of Mental Disorders" antidepressants, or their concentrations in plasma change dramatically in depressed individuals. Cortisone, cortisol, dehydroepiandrosterone (DHEA), estradiol, progesterone, pregnenolone, and testosterone are highly relevant to depression. Cortisone, cortisol, and cortisol/DHEA ratios were elevated in plasma after administration of an antidepressant agent. [7] [8] [9] The prevalence of depression is up to 3-fold higher in females than in males, 1 indicating that sex hormones could play a vital role in depression. For example, a correlation was found between daily estradiol levels and mood in women with postpartum depression one month after giving birth; estradiol withdrawal resulted in increased behavioral despair and depressive symptoms, while administration of estradiol to women with postpartum depression successfully reduced their depressive symptoms. 10 In addition, progesterone withdrawal can model hormonally induced mood disorders in women. 11 Testosterone has an antidepressant effect in depressed patients, especially in elderly subpopulations. 12 Pregnenolone associated with the improvement has been reported. 13 Changes in the plasma concentrations of these endogenous neuroactive steroids may therefore provide useful biomarkers to aid the diagnosis and treatment of depression. To date, these seven neuroactive steroids have not been investigated as biomarkers for depression. In addition, no methods have been developed that allow simultaneous determination of these neuroactive steroids in plasma.
Previously reported analytical procedures for the determination of neuroactive steroids have employed a variety of techniques including various immunoassays, 14 high-performance liquid chromatography (HPLC) with ultraviolet absorption detection, 15 gas chromatography-mass spectrometry (GC-MS), 16, 17 liquid chromatography-mass spectrometry, or liquid chromatographytandem mass spectrometry (LC-MS/MS). 16, 18, 19 Notably, recent developments in analytical techniques for steroids have led to the large-scale use of LC-MS/MS. [19] [20] [21] LC-MS/MS is increasingly becoming the method of choice for steroid hormone measurements due to small sample volumes, fast analysis times, the ability to simultaneously measure multiple analytes and high specificity compared to immunoassays. 22 LC-MS/MS is also superior to GC-MS that LC-MS/MS allows for high throughput testing with less sample preparation. 23 Because of these advantages, LC-MS/MS has become the method of choice for routine measurement of steroids and this plays an important role in the standardization and harmonization of measurements among clinical laboratories. 20, 24 In the present study, we took advantage of a well-recognized rat model of depression induced by the forced swim test (FST) 25 and developed an ethyl acetate extraction procedure for the seven neuroactive steroids from blood and brain tissue samples. In addition, we established and evaluated a sensitive and specific LC-MS/MS method for the simultaneous determination of these steroids and compared their concentrations in depressed and control rats. In our method, liquid-liquid extraction is simpler than others such as SPE or derivatization after extraction, which require more time and money; 26 the recovery of seven kinds of substances are high, and the integrated and systematic validation make the method more reliable. [26] [27] [28] It is the first time to establish the method to quantify the seven neurosteroids in rat plasma and brain following swim stress using LC-MS/MS. Our results showed that the concentrations of at least three neuroactive steroids (testosterone, progesterone, and pregnenolone) were highly elevated in the plasma of depressed rats, as compared to that in the control rats, implying that these have the potential to be developed as components of a specific biomarker panel for depression.
Experimental

Chemicals and reagents
Cortisone (99%) was purchased from Chromadex Inc. (California, USA). Cortisol (98.5%) was obtained from the National Institute for Food and Drug Control (Guangdong, China). Testosterone (98.5% purity) was obtained from Dr. Ehrenstorfer (Augsburg, Germany). Estradiol (≥97% purity) was obtained from Tokyo Chemical Industry Co., Ltd. (Shanghai, China). DHEA (98%) was purchased from Wuhan Yuangong Technology Co., Ltd. (Wuhan, China). Progesterone (98% purity) and pregnenolone (99% purity) were obtained from ACROS (NJ, USA). We synthesized 3,6-dihydroxy cholestane-24-ketone (98%) in our laboratory and used it as the internal standard (IS). Representative chemical structures are presented in Fig. 1 .
Ethyl acetate was obtained from Tianjin Fuyu Fine Chemical Co., Ltd. (Tianjin, China). Methanol for liquid chromatography was purchased from J&K Chemical (Beijing, China) and was of HPLC grade; all other reagents were of analytical purity. Highly pure water (reagent-grade deionized water) was obtained from ELGA PureLab Ultra (Buckinghamshire, England).
Chromatographic conditions
The HPLC analyses were carried out on a system consisting of an ACCELA Autosampler (Thermo Fisher, CA, USA) and ACCELA 1250 Pump (Thermo Fisher). The separation was performed on a Thermo Hypersil GOLD C18 column (2.1 × 100 mm, 1.9 μm) coupled with a C18 guard column (Thermo Fisher, PV, USA). The column was maintained at 40 C with a flow rate of 300 μL min -1 . The mobile phase consisted of highly pure water (A) and methanol (B) and gradient elution was used, according to the following profile: 0 -5 min, 20 -70% B; 5 -14 min, 70 -90% B; 14 -24 min, 90% B; 24 -26 min, 90 -20% B, and followed by 4 min equilibration. The injection volume was 10 μL. Under these conditions, the retention times for cortisone, cortisol, estradiol, testosterone, DHEA, progesterone, pregnenolone, and the IS were 5.7, 6.0, 7.0, 7.5, 7.8, 8.6, 9.6, and 11.8 min, respectively.
Mass spectrometric conditions
Quantification was achieved by MS/MS detection in the positive ion mode for the analytes and the IS using TSQ Quantum Access MAX (Thermo Fisher). The mass spectrometer was operated by atmospheric pressure chemical ionization (APCI) with selected reaction monitoring (SRM). The discharge current was set to 5 A. The vaporizer temperature and capillary temperature were 450 and 300 C, respectively. The sheath gas pressure and auxiliary gas pressure were 30 and 10 psi, respectively. The ion sweep gas pressure and skimmer offset were both set to 0. The operating conditions for MS/MS in SRM mode are listed in Table 1 . The column effluent was diverted to the ion source from 3.5 -20 min with the aid of a switching valve, housed on the mass spectrometer.
Preparation of standards and quality control (QC) samples
Stock solutions of cortisone, cortisol, estradiol, testosterone, DHEA, progesterone, pregnenolone, and IS were prepared in methanol at a concentration of 1.0 mg mL -1 . A series of working solutions of these analytes were prepared by diluting the stock solutions in methanol/H2O (50/50, v/v). These working solutions were then mixed together and stored in the dark at 4 C until use.
Calibration curves were prepared by spiking 20 μL of the working standard solutions with 500 μL of the rat plasma or brain homogenates. The blank samples were spiked with 20 μL methanol/H2O (50/50, v/v). All calibration curves were corrected by subtracting the ratio of the analyte to the IS peak area in blank biological samples. Calibration curves and QC samples were prepared during validation and for each experimental run.
Sample preparation protocol
Blood samples were centrifuged at 3500 rpm for 10 min and the plasma supernatants were stored at -20 C until analysis.
Brain tissue samples were frozen in liquid nitrogen and stored at -80 C. The samples were not thawed before homogenization. A piece of frozen brain tissue was weighed and homogenized using a glass homogenizer in normal saline solution (1 mL g -1 brain tissue). Brain homogenates were stored at -20 C until their analysis.
Plasma or brain homogenate samples (500 μL) were placed in a 5-mL centrifuge tube together with 20-μL aliquots of the working IS solution (1.0 μg mL -1 ). Butylated hydroxytoluene (50 ng mL -1 plasma) and EDTA·2Na (500 ng mL -1 plasma) were added and the mixture was vortexed vigorously for 30 s. Two-hundred microliters of NaOH solution (0.01 M in methanol) were added to the plasma samples (but not the brain tissue samples); all samples were then continuously agitated in an orbital shaker at 100 rpm in darkness at room temperature for 2 h. The samples were then extracted using 2.5 mL of ethyl acetate and vortexed for 5 min. After centrifugation at 3500 rpm for 10 min, the upper organic layers were transferred to clean tubes and dried at 37 C under a gentle stream of nitrogen. Each residue was reconstituted with 200 μL methanol/H2O (50/50, v/v), vortexed for 3 min, and centrifuged at 16000 rpm for 10 min. A 10-μL aliquot of the supernatant was then injected into the LC-MS/MS system for analysis.
Quantitative method validation
In accordance with the guidelines for "Industry: Bioanalytical Method Validation" (Food and Drug Administration, 2001), the developed method was validated for its linearity, limit of detection (LOD), limit of quantification (LOQ), precision (interday and intra-day precision), accuracy, matrix effect, and stability.
Animal study
Male Sprague-Dawley rats (250 ± 20 g, 45-to 50-day-old) were supplied by the Lab Animal Center at Guangzhou University of Chinese Medicine (Guangdong, China). The experimental protocol used was approved by the Ethics Committee of Sun Yat-Sen University.
The rats were housed in standard cages at room temperature with free access to food and water throughout the experiments. The modified FST was performed as previously described. 29 Rats were either placed in individual glass beakers (height 50 cm, diameter 25 cm) containing water (25 C) at a depth of 25 cm or left undisturbed. One day before the FST, the rats were forced to swim in water for a 15-min period (the pre-test phase). Thereafter, each rat was dried with a towel and returned to their home cage. On the test day, the rats were placed in the water tank for a 5-min period (the test phase) and their behavior was videotaped. Rats were then sedated with chloral hydrate and killed by decapitation after the 5-min FST. Blood and brain tissue samples were collected and prepared for analysis.
Calculation and statistical analysis
Spiked matrices were used for the calibration curves and unknown sample concentrations were calculated using Excel and Thermo Xcalibur (Thermo Xcalibur 2.1.0 SP1.1160) software.
Statistical analysis of the data was conducted using the Sigmaplot 11.0 program (Systat Software, Inc., CA, USA).
Results and Discussion
Method development Sample preparation optimization. To minimize interference from other endogenous biochemicals, it is necessary to develop a suitable pretreatment separation method. The extraction methods that are most commonly used for sample pretreatment are protein precipitation, liquid-liquid extraction, and solid phase extraction. 18, [30] [31] [32] Protein precipitation and liquid-liquid extraction were systematically compared. This study found that liquid-liquid extraction using ethyl acetate yielded the highest recoveries of the relevant analytes, with much less interference from other endogenous compounds that could cause ion suppression. In addition, liquid-liquid extraction is rapid, convenient, and has a considerably lower experimental cost than other techniques. NaOH was added before extraction because alkaline conditions improved analyte recovery. LC-MS/MS detection. To achieve the maximum sensitivity, the mass spectrometry parameters including the ionization mode (positive and negative), discharge current, vaporizer temperature, capillary temperature, sheath gas pressure, auxiliary gas pressure, and skimmer offset were firstly optimized by direct flow infusion of each standard. The results showed that APCI in positive mode was more sensitive for all the analytes and IS, than electrospray ionization. Several fragment ions were obtained in the precursor and product ion spectra and the ones that displayed the optimal intensity and reproducibility were selected, as shown in Table 1 .
The chromatographic conditions were optimized to exclude interference by endogenous substances. The best analyte response and the least background signal were achieved using a methanol/water mobile phase. Columns with small-sized particles and gradient elution were required to achieve effective separation of all the steroids, with simultaneous differentiation Fig. 2 Representative SRM chromatograms of blank plasma (A), a plasma sample spiked with all the analytes and IS (B), and a plasma sample from a rat that had completed the FST (C). (B) The spiked concentration of cortisol, cortisone, DHEA and pregnenolone in plasma was 5 ng mL -1 (plasma), and for the other compounds was 2 ng mL -1 (plasma). 1, Cortisone; 2, cortisol; 3, estradiol; 4, testosterone; 5, DHEA; 6, progesterone; 7, pregnenolone; 8, IS. Fig. 3 Typical SRM chromatograms of blank brain homogenate sample (A), a brain homogenate sample spiked with all the analytes and IS (B), and a brain homogenate sample from a rat that had completed the FST (C). (B) The spiked concentration of cortisol, cortisone and DHEA in brain homogenate was 10 ng mL -1 (brain), and for the other compounds was 4 ng mL -1 (brain). 1, Cortisone; 2, cortisol; 3, estradiol; 4, testosterone; 5, DHEA; 6, progesterone; 7, pregnenolone; 8, IS. from interference peaks. Under these conditions, this analysis facilitated detection of these seven molecules in one signal run, with the expected sensitivity and selectivity.
Method validation
Selectivity. The specific product ions and retention times of each neuroactive steroid and IS were used for quantification and to verify selectivity. The selectivity of the method was tested by comparing the chromatograms of a blank sample, spiked sample, and sample from a rat that had completed the FST. Typical chromatograms of plasma and brain homogenate samples are illustrated in Figs. 2 and 3 . These results indicated that the established method showed good selectivity for these analytes. Calibration curves, LOD, and LOQ. The linear range, regression equation, and correlation coefficient values for all the neuroactive steroids in plasma and brain homogenate samples are shown in Table 2 . Notably, all of the assays exhibited excellent linearity, with correlation coefficients >0.99 in the detected range of concentrations in both plasma and brain tissue.
The LOD and LOQ were defined when the signal:noise ratios were 3:1 and 10:1, respectively. The LOD and LOQ for all the analytes are presented in Table 2 . These indicated that the method provided sensitive determinations of the indicated neuroactive steroids in these samples. Precision and accuracy. The precision and accuracy of the method were evaluated by conducting five replicate analyses of QC plasma and brain homogenate samples containing low, medium, and high analyte concentrations on the same day (intra-day) and over three different days (inter-day). The concentrations were calculated using calibration curves that were obtained daily. The intra-and inter-day precision were expressed as the percent relative standard deviation (RSD%). The accuracy is presented as the percentage recovery (%R), which was calculated using the formula: %R = 100 ×(Mr -M0)/Mt, where Mr represents the amount (ng) of analyte determined in the spiked sample, M0 was the amount (ng) of analyte in the unspiked sample, and Mt was the theoretical amount (ng).
A summary of the precision and accuracy of this method for the determination of these analytes in the plasma and brain homogenate samples is provided in Table 3 . The accuracy values were 81.6 -109.7 and 87.7 -113.5% in samples with low and high concentrations, respectively. The intra-and interday accuracy values were ≤13.8 and 12.1%, respectively. Extraction recovery. For the determination of extraction recovery, blank plasma or brain homogenate samples were processed as described previously. Appropriate standards were then added to the organic layer at concentrations corresponding to the final concentrations of the QC samples before evaporating to dryness and reconstituting in the mobile phase. These spikeafter-extraction samples represented 100% recovery. The extraction recovery value for each analyte was determined by comparing the mean peak areas of five extracted low, medium, and high QC samples to the mean peak areas of five spike-afterextract samples at the same concentrations. As shown in Table 3 , the mean recovery values for the low-and highconcentration samples ranged from 83.1 -107.9 and 85.5 -113.7%, respectively, indicating efficient extraction recovery of these analytes from plasma and brain tissue samples.
Matrix effect.
Ion suppression (loss of signal) or ion enhancement (gain in signal) may be caused by a number of factors such as the matrix and interference from co-eluting compounds. [32] [33] [34] In the present context, matrix effects present a common problem while analyzing compounds in biological samples using LC-MS/MS and may be a major cause of ion suppression. 31, 32 These matrix effects can be difficult to eliminate and may negatively affect several analytical parameters such as detection capability, precision, and accuracy. 35 We investigated matrix effects on analyte ionization by comparing the analyte peak areas in the blank sample (the final solution of blank plasma after extraction and reconstitution) with those resolved in mobile phase that was spiked with the same analyte concentrations. Two different concentrations of analytes were evaluated in triplicate. As shown in Tables 4 and 5, the matrix effects in the presence of low and high analyte concentrations were in the range of 81.0 -113.3 and 85.6 -111.3%, respectively. The matrix effects were thus within acceptable variability limits. Stability. The stabilities of the seven neuroactive steroids in plasma and brain tissue homogenate were measured using the low-and high-concentration QC samples. The samples were stored at room temperature for 8 or 24 h or frozen at -20 C. Freeze-thaw stability was evaluated after two freeze-thaw cycles from -20 C to room temperature. Stability was expressed as the percentage relative error (RE%). As shown in Tables 4 and 5 , the analyte concentrations detected in these samples were nearly identical to those detected in freshly prepared QC samples, with RE values of ≤11.2%. These data indicated that plasma and brain tissue samples containing all of the analytes might be kept for up to 24 h at ambient temperature during routine analyses, and that two freeze-thaw cycles on consecutive days did not result in any significant analyte degradation.
Method application
As shown in Table 6 , plasma concentrations of testosterone, progesterone, and pregnenolone significantly increased (p <0.05) in rats that had completed the FST, as compared to that in the control group. Previous reports hypothesized that altered sex hormone levels could cause postpartum depression. 36, 37 No change in the estradiol level was detected because we used male rats only.
As shown in Table 6 , the brain homogenate levels of cortisol, estradiol, and progesterone markedly decreased in rats exposed to the FST. In fact, the concentrations of cortisol and estradiol are below the LOD.
In contrast, the concentration of pregnenolone significantly increased. Pregnenolone is the precursor of progestogens, mineralocorticoids, glucocorticoids, androgens, and estrogens, and it has been shown to exert antidepressant effects. 38 These results suggest that the increased level of pregnenolone may be a compensatory response to the depression induced in rats by FST; there may also be some changes in the activity levels of enzymes such as 11β-hydroxylase, cytochrome P450 19, and 3β-hydroxysteroid dehydrogenase, which result in the observed reductions in the concentrations of cortisol, estradiol, and progesterone, respectively. These results have provided information relating to the mechanisms underlying depression and antidepressant effects. FST altered these neuroactive steroid levels and regulation of these, or their metabolic and/or synthetic enzymes, could be targeted by antidepressants.
This non-invasive measurement of testosterone, progesterone, and pregnenolone in plasma could provide an effective approach to the diagnosis of depression and our results indicate that a larger exploration of this in humans is warranted. Three of the seven selected steroids may have the potential to be developed further as components of a biomarker panel for the diagnosis and treatment of depression. Analysis of this panel in this rat model of FST-induced depression could also provide a screening system for antidepressants. 
Conclusion
A simple, sensitive, and reliable LC-MS/MS method was developed and validated for the first time for the simultaneous determination of seven depression-related neuroactive steroids in rat plasma and brain, including cortisol, cortisone, testosterone, estradiol, progesterone, DHEA, and pregnenolone. This LC-MS/MS analysis used an APCI technique with satisfactory mass spectral response in a positive ion mode. The method was successfully applied to simultaneously determine seven neuroactive steroids in the plasma and brains of rats exposed to the FST, a classic rodent model of depression. Compared with the control group, the FST group showed significantly elevated plasma levels of testosterone, progesterone, and pregnenolone. In the brain of FST rats, the levels of cortisol, estradiol, and pregnenolone significantly decreased, whereas the level of pregnenolone markedly increased. These FST-related changes in neuroactive steroid concentration, especially those observed in plasma, could serve as potential biomarkers for the diagnosis and treatment of depression. Control rats were not exposed to the FST; ND, not detected. a. p <0.05.
